Published in
American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 6(46), p. 1974-1976, 2002
DOI: 10.1128/aac.46.6.1974-1976.2002
Links
- ORCID
- American Society for Microbiology | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Amphotericin B Formulations Exert Additive Antifungal Activity in Combination with Pulmonary Alveolar Macrophages and Polymorphonuclear Leukocytes against Aspergillus fumigatus
Journal article published in 2002 by
Emmanuel Roilides,
Caron A. Lyman,
Joanna Filioti,
Onome Akpogheneta 
,
Tin Sein,
Cristina Gil Lamaignere,
Ruta Petraitiene,
Thomas J. Walsh
,
Tin Sein,
Cristina Gil Lamaignere,
Ruta Petraitiene,
Thomas J. Walsh
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
ABSTRACT Deoxycholate amphotericin B (DAMB) and amphotericin B lipid complex (ABLC) additively augmented the fungicidal activity of pulmonary alveolar macrophages against the conidia of Aspergillus fumigatus . DAMB, ABLC, and liposomal amphotericin B similarly displayed additive effects with polymorphonuclear leukocytes in damaging the hyphal elements of A. fumigatus .